Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive celecoxib for postoperative pain after mandibular third molar surgery
PACTR202311897703701Completed
- Sponsor
- Stephen Solomon
- Start
- Sep 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of celecoxib in postoperative pain (2 arms), sponsored by Stephen Solomon. Primary endpoints: Postoperative pain control and Quality of life. Started Sep 2023; status: completed.
02
Drugs
celecoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202311897703701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202311897703701.